Skip navigation
Skip navigation

Development of Indicators to Assess Quality of Care for Prostate Cancer

Nag, N; Millar, Jeremy; Davis, Ian; Costello, S; Duthie, J; Mark, S; Delprado, W; Smith, David; Pryor, D; Galvin, D; Elsaleh, Hany

Description

Background: The development, monitoring, and reporting of indicator measures that describe standard of care provide the gold standard for assessing quality of care and patient outcomes. Although indicator measures have been reported, little evidence of their use in measuring and benchmarking performance is available. A standard set, defining numerator, denominator, and risk adjustments, will enable global benchmarking of quality of care. Objective: To develop a set of indicators to enable...[Show more]

dc.contributor.authorNag, N
dc.contributor.authorMillar, Jeremy
dc.contributor.authorDavis, Ian
dc.contributor.authorCostello, S
dc.contributor.authorDuthie, J
dc.contributor.authorMark, S
dc.contributor.authorDelprado, W
dc.contributor.authorSmith, David
dc.contributor.authorPryor, D
dc.contributor.authorGalvin, D
dc.contributor.authorElsaleh, Hany
dc.date.accessioned2019-09-09T05:32:18Z
dc.identifier.issn2405-4569
dc.identifier.urihttp://hdl.handle.net/1885/165925
dc.description.abstractBackground: The development, monitoring, and reporting of indicator measures that describe standard of care provide the gold standard for assessing quality of care and patient outcomes. Although indicator measures have been reported, little evidence of their use in measuring and benchmarking performance is available. A standard set, defining numerator, denominator, and risk adjustments, will enable global benchmarking of quality of care. Objective: To develop a set of indicators to enable assessment and reporting of quality of care for men with localised prostate cancer (PCa). Design, setting, and participants: Candidate indicators were identified from the literature. An international panel was invited to participate in a modified Delphi process. Teleconferences were held before and after each voting round to provide instruction and to review results. Outcome measurements and statistical analysis: Panellists were asked to rate each proposed indicator on a Likert scale of 1–9 in a two-round iterative process. Calculations required to report on the endorsed indicators were evaluated and modified to reflect the data capture of the Prostate Cancer Outcomes Registry–Australia and New Zealand (PCOR-ANZ). Results and limitations: A total of 97 candidate indicators were identified, of which 12 were endorsed. The set includes indicators covering pre-, intra-, and post-treatment of PCa care, within the limits of the data captured by PCOR-ANZ. Conclusions: The 12 endorsed quality measures enable international benchmarking on the quality of care of men with localised PCa. Reporting on these indicators enhances safety and efficacy of treatment, reduces variation in care, and can improve patient outcomes. Patient summary: PCa has the highest incidence of all cancers in men. Early diagnosis and relatively high survival rates mean issues of quality of care and best possible health outcomes for patients are important. This paper identifies 12 important measurable quality indicators in PCa care. This paper identifies 12 important measurable quality indicators in prostate cancer care. These measures provide a global standard for registries to benchmark quality of care of men with localised prostate cancer.
dc.format.mimetypeapplication/pdf
dc.language.isoen_AU
dc.publisherElsevier B.V
dc.rights©2018. Elsevier Inc.
dc.sourceEuropean Urology Focus
dc.titleDevelopment of Indicators to Assess Quality of Care for Prostate Cancer
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume4
dc.date.issued2018
local.identifier.absfor111208 - Radiation Therapy
local.identifier.ariespublicationu5369653xPUB87
local.publisher.urlhttps://www.elsevier.com/en-au
local.type.statusPublished Version
local.contributor.affiliationNag, N, Monash University
local.contributor.affiliationMillar, Jeremy, Radiation Oncology, Alfred Health
local.contributor.affiliationDavis, Ian, Monash University Eastern Health Clinical School
local.contributor.affiliationCostello, S, Christchurch District Health Board
local.contributor.affiliationDuthie, J, Bay Urology
local.contributor.affiliationMark, S, Christchurch Hospital
local.contributor.affiliationDelprado, W, Douglass Hanly Moir Pathology
local.contributor.affiliationSmith, David, Cancer Council NSW
local.contributor.affiliationPryor, D, Queensland University of Technology
local.contributor.affiliationGalvin, D, St. Vincent's University
local.contributor.affiliationElsaleh, Hany, College of Health and Medicine, ANU
local.description.embargo2037-12-31
local.bibliographicCitation.issue1
local.bibliographicCitation.startpage57
local.bibliographicCitation.lastpage63
local.identifier.doi10.1016/j.euf.2016.01.016
local.identifier.absseo920102 - Cancer and Related Disorders
dc.date.updated2019-04-14T08:29:50Z
local.identifier.scopusID2-s2.0-85048625384
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Nag_Development_of_Indicators_to_2018.pdf217.2 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator